- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 834790, 9 pages
Development of a Novel System for Mass Spectrometric Analysis of Cancer-Associated Fucosylation in Plasma α1-Acid Glycoprotein
1Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan
2Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0192, Japan
3Institute of Biomedical Innovation, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0192, Japan
4S-BIO Business Division, Sumitomo Bakelite Co., Ltd., Tokyo 140-0002, Japan
5JIMRO Co., Ltd., Tokyo 151-0063, Japan
Received 3 November 2012; Accepted 13 December 2012
Academic Editor: Tavan Janvilisri
Copyright © 2013 Takayuki Asao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. F. G. Vliegenthart and J. Motreuil, “Primary structure of glycoprotein glycans,” in Glycoproteins, J. Montreuil, J. F. G. Vliegenthart, and H. Schachter, Eds., pp. 13–28, Elsevier, Amsterdam, The Netherlands, 1995.
- W. van Dijk, E. C. Havenaar, and E. C. M. Brinkman-van der Linden, “Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function,” Glycoconjugate Journal, vol. 12, no. 3, pp. 227–233, 1995.
- S. Hashimoto, T. Asao, J. Takahashi et al., “-Acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis,” Cancer, vol. 101, no. 12, pp. 2825–2836, 2004.
- P. Laurent, L. Miribel, J. Bienvenu, C. Vallve, and P. Arnaud, “A three-step purification of human alpha 1-acid glycoprotein,” FEBS Letters, vol. 168, no. 1, pp. 79–83, 1984.
- J. Chan and D. Yu, “One-step isolation of alpha 1-acid glycoprotein,” Protein Expression and Purification, vol. 2, no. 1, pp. 34–36, 1991.
- F. Hervé, M. C. Millot, C. B. Eap, J. C. Duché, and J. P. Tillement, “Two-step chromatographic purification of human plasma α1-acid glycoprotein. Its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent,” Journal of Chromatography B, vol. 678, no. 1, pp. 1–14, 1996.
- I. Rydén, G. Skude, A. Lundblad, and P. Påhlsson, “Glycosylation of -acid glycoprotein in inflammatory disease: analysis by high-pH anion-exchange chromatography and concanavalin A crossed affinity immunoelectrophoresis,” Glycoconjugate Journal, vol. 14, no. 4, pp. 481–488, 1997.
- T. R. McCurdy, V. Bhakta, L. J. Eltringham-Smith, S. Gataiance, A. E. Fox-Robichaud, and W. P. Sheffield, “Comparison of methods for the purification of alpha-1 acid glycoprotein from human plasma,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 578207, 9 pages, 2011.
- S. Ongay, I. Lacunza, J. C. Diez-Masa, J. Sanz, and M. de Frutos, “Development of a fast and simple immunochromatographic method to purify alpha-1-acid glycoprotein from serum for analysis of its isoforms by capillary electrophoresis,” Analytica Chimica Acta, vol. 663, no. 2, pp. 206–212, 2010.
- K. Shimura, M. Tamura, T. Toda, S. Yazawa, and K.-I. Kasai, “Quantitative evaluation of lectin-reactive glycoforms of α1-acid glycoprotein using lectin affinity capillary electrophoresis with fluorescence detection,” Electrophoresis, vol. 32, no. 16, pp. 2188–2193, 2011.
- R. Uematsu, J. I. Furukawa, H. Nakagawa et al., “High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis,” Molecular and Cellular Proteomics, vol. 4, no. 12, pp. 1977–1989, 2005.
- Y. Kita, Y. Miura, J. I. Furukawa et al., “Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans,” Molecular and Cellular Proteomics, vol. 6, no. 8, pp. 1437–1445, 2007.
- Y. Miura, M. Hato, Y. Shinohara et al., “BlotGlycoABC, an integrated glycoblotting technique for rapid and large scale clinical glycomics,” Molecular and Cellular Proteomics, vol. 7, no. 2, pp. 370–377, 2008.
- T. Imre, T. Kremmer, K. Héberger et al., “Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals,” Journal of Proteomics, vol. 71, no. 2, pp. 186–197, 2008.
- J. E. Hansen, V. A. Larsen, and T. C. Bøg-Hansen, “The microheterogeneity of alpha-1-acid glycoprotein in inflammatory lung disease, cancer of the lung and normal health,” Clinica Chimica Acta, vol. 138, no. 1, pp. 41–47, 1984.
- P. Hrycaj, M. Sobieska, S. Mackiewicz, and W. Muller, “Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis,” Journal of Rheumatology, vol. 20, no. 12, pp. 2020–2024, 1993.
- T. W. De Graaf, M. E. van der Stelt, M. G. Anbergen, and W. van Dijk, “Inflammation-induced expression of sialyl Lewis X-containing glycan structures on -acid glycoprotein (orosomucoid) in human sera,” The Journal of Experimental Medicine, vol. 177, no. 3, pp. 657–666, 1993.
- E. C. Havenaar, J. S. Axford, E. C. M. Brinkman-van Der Linden et al., “Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in α3-fucosylation of -acid glycoprotein,” Glycoconjugate Journal, vol. 15, no. 7, pp. 723–729, 1998.
- H. G. Jorgensen, M. A. Elliott, R. Priest, and K. D. Smith, “Modulation of sialyl Lewis X dependent binding to E-selection by glycoforms of alpha-1-acid glycoprotein expressed in rheumatoid arthritis,” Biomedical Chromatography, vol. 12, no. 6, pp. 343–349, 1998.
- W. van Dijk, C. Koeleman, B. van het Hof, D. Poland, C. Jakobs, and J. Jaeken, “Increased α3-fucosylation of α1-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia),” FEBS Letters, vol. 494, no. 3, pp. 232–235, 2001.
- T. Zimmerman-Belsing, U. Feldt-Rasmussen, G. From, H. Perrild, and T. C. Bøg-Hansen, “Long-term pathologic changes of alpha 1-acid glycoprotein (orosomucoid) glycoforms in autoimmune thyroid disease,” Autoimmunity, vol. 35, no. 7, pp. 441–447, 2002.
- F. Ceciliani and V. Pocacqua, “The acute phase protein -acid glycoprotein: a model for altered glycosylation during diseases,” Current Protein and Peptide Science, vol. 8, no. 1, pp. 91–108, 2007.
- K. M. Chiu, R. F. Mortensen, A. P. Osmand, and H. Gewurz, “Interactions of α1-acid glycoprotein with the immune system. I Purification and effects upon lymphocyte responsiveness,” Immunology, vol. 32, no. 6, pp. 997–1005, 1977.
- J. M. H. Kremer, J. Wilting, and L. H. M. Janssen, “Drug binding to human -acid glycoprotein in health and disease,” Pharmacological Reviews, vol. 40, no. 1, pp. 1–47, 1988.
- C. Libert, P. Brouckaert, and W. Fiers, “Protection by α1-acid glycoprotein against tumor necrosis factor-induced lethality,” Journal of Experimental Medicine, vol. 180, no. 4, pp. 1571–1575, 1994.
- T. Fournier, N. Medjoubi-N, and D. Porquet, “Alpha-1-acid glycoprotein,” Biochimica et Biophysica Acta, vol. 1482, no. 1-2, pp. 157–171, 2000.
- A. Mackiewicz and K. Mackiewicz, “Glycoforms of serum alpha-1-acid glycoprotein as markers of inflammation and cancer,” Glycoconjugate Journal, vol. 12, no. 3, pp. 241–247, 1995.
- I. Rydén, P. Påhlsson, A. Lundblad, and T. Skogh, “Fucosylation of -acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis,” Clinica Chimica Acta, vol. 317, no. 1-2, pp. 221–229, 2002.
- D. C. W. Poland, J. J. G. Vallejo, H. W. M. Niessen et al., “Activated human PMN synthesize and release a strongly fucosylated glycoform of -acid glycoprotein, which is transiently deposited in human myocardial infarction,” Journal of Leukocyte Biology, vol. 78, no. 2, pp. 453–461, 2005.
- K. Higai, Y. Aoki, Y. Azuma, and K. Matsumoto, “Glycosylation of site-specific glycans of -acid glycoprotein and alterations in acute and chronic inflammation,” Biochimica et Biophysica Acta, vol. 1725, no. 1, pp. 128–135, 2005.
- S. Ongay, C. Neusüß, S. Baas, J. C. Diez-Masa, and M. De Frutos, “Evaluation of the effect of the immunopurification-based procedures on the CZE-UV and CZE-ESI-TOF-MS determination of isoforms of intact α-1-acid glycoprotein from human serum,” Electrophoresis, vol. 31, no. 11, pp. 1796–1804, 2010.
- T. Kremmer, É. Szöllösi, M. Boldizsár et al., “Liquid chromatographic and mass spectrometric analysis of human serum acid alpha-1-glycoprotein,” Biomedical Chromatography, vol. 18, no. 5, pp. 323–329, 2004.
- M. Nakano, K. Kakehi, M. H. Tsai, and Y. C. Lee, “Detailed structural features of glycan chains derived from α1-acid glycoproteins of several different animals: the presence of hypersialylated, O-acetylated sialic acids but not disialy1 residues,” Glycobiology, vol. 14, no. 5, pp. 431–441, 2004.
- A. Kuno, Y. Ikehara, Y. Tanaka et al., “Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray,” Clinical Chemistry, vol. 57, no. 1, pp. 48–56, 2011.